With little direct competition in patch pumps, Insulet has been able to convert more users, especially patients on multiple daily injections, to its innovative, tubeless insulin pump. The firm has ...

The lawsuit revolved around Insulet's Omnipod tubeless insulin pump – used with continuous glucose monitors (CGMs) to create an artificial pancreas system used by diabetics – and claimed that ...

A recently published study highlighted the strong performance of the Insulet (Nasdaq:PODD) Omnipod 5 in children and young ...

(Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, will host an Investor Day at the Company's global headquarters in Acton ...

Insulet Corp ... including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and ...

With little direct competition in patch pumps, Insulet has been able to convert more users, especially patients on multiple daily injections, to its innovative, tubeless insulin pump. The firm is ...

The automated insulin delivery (AID ... AID system cleared by the FDA for people with Type 2 diabetes, after Insulet’s Omnipod 5 received an expanded indication last summer.

Feb 20(Reuters) - Insulet (PODD.O), opens new ... driven by strong demand for its wearable insulin pumps. The company produces and sells Omnipod, an automated insulin delivery device, which ...